Article | July 18, 2023

Using Robotics In The ATMP Space

Source: AST

By Josh Russell

Vials getting ready

The use of robotics to manufacture Advanced Therapy and Medicinal Products (ATMP) solves many challenges, including significantly limiting exposure to human-generated contamination. There are steps to mitigate contamination points but with the strong endorsements recently made within the current revision to Annex I encouraging the use of robotics (Section 8.9)1, eliminating human interventions should be considered seriously.

Learn about the regulatory requirements and GMP recommendations that are trending towards less human interaction and more robotic automation as well as the reasons robotics is the way of the future for the ATMP industry.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Cell & Gene